This workshop provided an open discussion forum to identify, propose and prioritise specific challenges, success and risk factors in the development of vaccines against nosocomial AMR pathogens. Participants included experts in clinical vaccine development from industry, academia and regulatory agencies, as well as experts in innovative clinical trial designs. General discussion topics covered pre-existing clinical […]
Each year, World Tuberculosis (TB) Day is commemorated on March 24 to raise public awareness about the devastating health, social and economic consequences of TB, and to step up efforts to end the global TB epidemic. The date marks the day in 1882 when Dr Robert Koch announced that he had discovered the bacterium that […]
Bringing together 60+ senior leaders from large pharma, innovative biotech, academia and investment companies, this conference will discuss data-driven and solution-based approaches that focus on developing high value clinical candidates, novel modalities and effective strategies, that address market sustainability and aim for superiority.
As AMR emerges, new strategies for the treatment of infection and identification of resistant microbes are crucial. This JPIAMR activity, led by the UK Medical Research Council (MRC) with support from South Africa (SAMRC), Korea (NRF), France (ANR), and Canada (CIHR) is delivered as part of JPIAMR’s mission to enable global coordination of research. The […]
The COMBINE project is part of the IMI AMR Accelerator. One of the scientific aims of COMBINE is to improve and standardize the pneumonia animal model used in AMR research and to develop improved tools to reliably translate results in animals into results in humans. This workshop addressed the need for standard protocols to ease […]
This live webinar will discuss the following topics: Are CMC and formulation efforts treated as the foster child in the innovation and development armament? Underestimating CMC and formulation aspects can potentially cause significant delays and project failures Appropriate (what, how and when) CMC and formulation innovation and development strategies can improve overall probability of project […]
This webinar provided a unique opportunity for the antibiotic community. The Innovative Medicines Initiative's GNA NOW Consortium was looking for a novel antibiotic compound to progress to a clinical candidate and informed participants about what was in it for interested candidates, and how to submit a proposal, among others. View the agenda and register now. […]
This webinar will cover the use of knowledge management tools in the IMI AMR Accelerator and how these can be used to both enhance data analysis workflows and also promote collaborations across projects and teams. To support these efforts the AMR Data Management group have developed a set of database and visualisation tools based […]
GNA NOW Open Call webinar II This webinar provided a unique opportunity for the antibiotic community. The Innovative Medicines Initiative’s GNA NOW Consortium was looking for a novel antibiotic compound to progress to a clinical candidate and informed participants about what was in it for interested candidates, and how to submit a proposal, among others.
New clinical trial designs for evaluation of antimicrobial agents Speakers: David Paterson, Director, University of Queensland Centre for Clinical Research (Australia) Julie Marsh, Biostatistical Lead, Wesfarmers Centre of Vaccines and Infectious Diseases, University of Western Australia (Australia) Moderator: Tom Snelling, Professor of Infectious Diseases and Director of the Health and Clinical Analytics lab, Sydney School of […]
